Noble.MD, a health IT company that launched a product called Theo to initiate self-guided risk assessments through questionnaires, has raised a fresh round of capital from investors. The funding will be ramp up its sales and marketing teams across traditional and digital media channels, according to a company statement.
The health IT company is rolling out a couple of population health products: one for Medicare Annual Wellness Visits, and another for hip and knee surgeries for providers operating under the Complete Joint Replacement payment bundle.
Led by Founder and CEO Dr. Todd Johnson, Noble.MD raised $1.45 million from Safeguard Scientifics and BioAdvance, a new investor, took part in the round with individual angel investors.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
“We have been helping our clients build their patient-reported population health databases for years. Now we are using that expertise to help our clients directly and immediately enhance their revenue,” said Johnson. “Patient-reported data is the uncut diamond of healthcare – it is the key to prospective risk identification.”
Noble.MD, which got started in 2012, has expanded its risk assessment and and patient education tools with predictive analytics. One area it identified for improvement were Human Papillomavirus vaccination rates. To that effect, it embarked on a study with Children’s Hospital of Philadelphia last year.
